rs142735148

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_005477.3(HCN4):​c.3337A>G​(p.Met1113Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0133 in 1,562,790 control chromosomes in the GnomAD database, including 163 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.010 ( 11 hom., cov: 33)
Exomes 𝑓: 0.014 ( 152 hom. )

Consequence

HCN4
NM_005477.3 missense

Scores

2
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:15

Conservation

PhyloP100: -0.425
Variant links:
Genes affected
HCN4 (HGNC:16882): (hyperpolarization activated cyclic nucleotide gated potassium channel 4) This gene encodes a member of the hyperpolarization-activated cyclic nucleotide-gated potassium channels. The encoded protein shows slow kinetics of activation and inactivation, and is necessary for the cardiac pacemaking process. This channel may also mediate responses to sour stimuli. Mutations in this gene have been linked to sick sinus syndrome 2, also known as atrial fibrillation with bradyarrhythmia or familial sinus bradycardia. Two pseudogenes have been identified on chromosome 15. [provided by RefSeq, Oct 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0025372803).
BP6
Variant 15-73322756-T-C is Benign according to our data. Variant chr15-73322756-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 137543.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-73322756-T-C is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.0102 (1549/152286) while in subpopulation SAS AF= 0.0207 (100/4826). AF 95% confidence interval is 0.0174. There are 11 homozygotes in gnomad4. There are 691 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1549 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HCN4NM_005477.3 linkc.3337A>G p.Met1113Val missense_variant Exon 8 of 8 ENST00000261917.4 NP_005468.1 Q9Y3Q4
HCN4XM_011521148.3 linkc.2119A>G p.Met707Val missense_variant Exon 7 of 7 XP_011519450.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HCN4ENST00000261917.4 linkc.3337A>G p.Met1113Val missense_variant Exon 8 of 8 1 NM_005477.3 ENSP00000261917.3 Q9Y3Q4

Frequencies

GnomAD3 genomes
AF:
0.0102
AC:
1548
AN:
152170
Hom.:
11
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00637
Gnomad AMI
AF:
0.0340
Gnomad AMR
AF:
0.00962
Gnomad ASJ
AF:
0.0141
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0205
Gnomad FIN
AF:
0.00198
Gnomad MID
AF:
0.0348
Gnomad NFE
AF:
0.0132
Gnomad OTH
AF:
0.0148
GnomAD3 exomes
AF:
0.0116
AC:
1855
AN:
159446
Hom.:
12
AF XY:
0.0125
AC XY:
1074
AN XY:
85932
show subpopulations
Gnomad AFR exome
AF:
0.00758
Gnomad AMR exome
AF:
0.00807
Gnomad ASJ exome
AF:
0.0157
Gnomad EAS exome
AF:
0.0000769
Gnomad SAS exome
AF:
0.0213
Gnomad FIN exome
AF:
0.00228
Gnomad NFE exome
AF:
0.0141
Gnomad OTH exome
AF:
0.0156
GnomAD4 exome
AF:
0.0136
AC:
19193
AN:
1410504
Hom.:
152
Cov.:
36
AF XY:
0.0140
AC XY:
9740
AN XY:
696756
show subpopulations
Gnomad4 AFR exome
AF:
0.00727
Gnomad4 AMR exome
AF:
0.00864
Gnomad4 ASJ exome
AF:
0.0151
Gnomad4 EAS exome
AF:
0.0000531
Gnomad4 SAS exome
AF:
0.0234
Gnomad4 FIN exome
AF:
0.00252
Gnomad4 NFE exome
AF:
0.0140
Gnomad4 OTH exome
AF:
0.0152
GnomAD4 genome
AF:
0.0102
AC:
1549
AN:
152286
Hom.:
11
Cov.:
33
AF XY:
0.00928
AC XY:
691
AN XY:
74448
show subpopulations
Gnomad4 AFR
AF:
0.00645
Gnomad4 AMR
AF:
0.00954
Gnomad4 ASJ
AF:
0.0141
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.0207
Gnomad4 FIN
AF:
0.00198
Gnomad4 NFE
AF:
0.0132
Gnomad4 OTH
AF:
0.0147
Alfa
AF:
0.0131
Hom.:
3
Bravo
AF:
0.0108
TwinsUK
AF:
0.0124
AC:
46
ALSPAC
AF:
0.0132
AC:
51
ESP6500AA
AF:
0.00669
AC:
29
ESP6500EA
AF:
0.0126
AC:
107
ExAC
AF:
0.00817
AC:
953
Asia WGS
AF:
0.00779
AC:
27
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:15
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:7
-
Clinical Genetics, Academic Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Feb 19, 2014
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Apr 10, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jun 29, 2017
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 26, 2016
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:3
Nov 21, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

HCN4: BS1, BS2 -

Sick sinus syndrome 2, autosomal dominant Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Cardiomyopathy Benign:1
Sep 08, 2017
Center for Advanced Laboratory Medicine, UC San Diego Health, University of California San Diego
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Sick sinus syndrome 2, autosomal dominant;C2751083:Brugada syndrome 8;C5561983:Epilepsy, idiopathic generalized, susceptibility to, 18 Benign:1
Aug 13, 2021
Fulgent Genetics, Fulgent Genetics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Brugada syndrome 8 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Cardiovascular phenotype Benign:1
Aug 17, 2015
Ambry Genetics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.046
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.40
CADD
Benign
0.18
DANN
Benign
0.36
DEOGEN2
Benign
0.18
T
Eigen
Benign
-1.8
Eigen_PC
Benign
-1.8
FATHMM_MKL
Benign
0.0046
N
LIST_S2
Benign
0.32
T
MetaRNN
Benign
0.0025
T
MetaSVM
Benign
-0.31
T
MutationAssessor
Benign
-0.81
N
PrimateAI
Uncertain
0.61
T
PROVEAN
Benign
-0.020
N
REVEL
Uncertain
0.31
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.0
B
Vest4
0.042
MPC
0.18
ClinPred
0.000010
T
GERP RS
-5.1
Varity_R
0.045
gMVP
0.19

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs142735148; hg19: chr15-73615097; API